Baader Bank Aktiengesellschaft’s Rubius Therapeutics, Inc RUBY Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio RUBY Stock Details RUBY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-73,420	Closed	-$1.22K	–	526
2023 Q1	$1.22K	Buy	+73,420	New	+$15.3K	﹤0.01%	374

Baader Bank Aktiengesellschaft's RUBY Position: Q2 2023 in Review

Baader Bank Aktiengesellschaft sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2023, closing a stake of 73,420 shares — an estimated $1.22K sold.

Baader Bank Aktiengesellschaft first reported a position in RUBY in Q1 2023 and held it in 1 quarter. The position peaked at $1.22K in Q1 2023. 0 funds tracked by Wall St. Rank hold RUBY as of Q2 2023.

Baader Bank Aktiengesellschaft reported no remaining Rubius Therapeutics, Inc position as of Q2 2023 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 73,420 Rubius Therapeutics, Inc shares in Q2 2023, an estimated $1.22K.
Baader Bank Aktiengesellschaft first reported a position in Rubius Therapeutics, Inc in Q1 2023 and held it in 1 quarter.
Baader Bank Aktiengesellschaft's Rubius Therapeutics, Inc position peaked at $1.22K in Q1 2023.
0 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2023.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2023, filed 11 Aug 2023.